| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Protein kinase C, alpha (PRKCA) from ORIGENE TECHNOLOGIES | LY400966 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419140 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419141 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403918 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403923 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, gamma (PRKACG) from ORIGENE TECHNOLOGIES | LY419142 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 6 from ORIGENE TECHNOLOGIES | LY402041 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 7 from ORIGENE TECHNOLOGIES | LY430578 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405588 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 7 from ORIGENE TECHNOLOGIES | LY405612 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430565 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405587 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405596 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430570 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 3 from ORIGENE TECHNOLOGIES | LY410103 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416230 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405595 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430569 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431006 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400963 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403944 | 100 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, left; Adenocarcinoma of breast, ductal, metastatic from ORIGENE TECHNOLOGIES | CR562547 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, left; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIES | CR562606 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, left; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIES | CR561926 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, normal from ORIGENE TECHNOLOGIES | CR559198 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, normal from ORIGENE TECHNOLOGIES | CR559173 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562418 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR559439 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, normal from ORIGENE TECHNOLOGIES | CR636414 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562540 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562527 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal, mucinous from ORIGENE TECHNOLOGIES | CR561878 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR566340 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal, recurrent from ORIGENE TECHNOLOGIES | CR562574 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, ductal, inflammatory from ORIGENE TECHNOLOGIES | CR562336 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right lateral; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562468 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Adenocarcinoma of breast, lobular from ORIGENE TECHNOLOGIES | CR561891 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast, right; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIES | CR562566 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cartilage; Chondrosarcoma from ORIGENE TECHNOLOGIES | CR562593 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cartilage; Chondrosarcoma, recurrent from ORIGENE TECHNOLOGIES | CR559449 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cartilage; Chondrosarcoma, recurrent from ORIGENE TECHNOLOGIES | CR562299 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cartilage; Chondrosarcoma, recurrent from ORIGENE TECHNOLOGIES | CR559448 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560190 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560194 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560316 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560304 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560251 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560367 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560333 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Cecum; Adenocarcinoma of colon from ORIGENE TECHNOLOGIES | CR560476 | 5 ug | ORIGENE TECHNOLOGIES |